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Abstract 
 
The recent developments in cryo-EM have revolutionized our access to previously 
refractory structures. In particular, such studies of mammalian mitoribosomes have 
confirmed the absence of any 5S rRNA species and revealed the unexpected 
presence of a mitochondrially encoded tRNA (mt-tRNA) that usurps this position. 
Although the cryo-EM structures resolved the conundrum of whether mammalian 
mitoribosomes contain a 5S rRNA, they introduced a new dilemma - why do human 
and porcine mitoribosomes integrate contrasting mt-tRNAs? 
 
Human mitoribosomes have been shown to integrate mt-tRNAVal, compared to the 
porcine use of mt-tRNAPhe. We have explored this observation further. Our studies 
examine i) whether a range of mt-tRNAs are used by different mammals, or if the mt-
tRNA selection is strictly limited to only these two species out of the twenty two 
tRNAs encoded by the mitochondrial genome (mtDNA); ii) if there is tissue-specific 
variation within a single organism and iii) what happens to the human mitoribosome 
when levels of the mt-tRNAVal are depleted. 
 
Our data demonstrate that i) only mt-tRNAVal or mt-tRNAPhe are found in the 
mitoribosomes of five different mammals; ii) each mammal favours the same mt-
tRNA in all tissue types and iii) strikingly, when steady state level of mt-tRNAVal are 
reduced, human mitoribosome biogenesis displays an adaptive response by 
switching to the incorporation of mt-tRNAPhe to generate translationally competent 
machinery. 
 
 
Significance Statement 
Mammalian mitoribosomes are idiosyncratic. They have reversed the typical 70% 
RNA:30% protein ratio to generate a protein rich ribosome, which lacks the 
conventional 5S transcript as a third rRNA component. Recent sub-nm-resolution 
structures revealed a further unexpected eccentricity, the integration of a 
mitochondrially-encoded tRNA into the large-subunit structure. However, mt-tRNA 
selection varies with mt-tRNAVal integration into human mitoribosomes, compared to 
porcine mitoribosomes favouring mt-tRNAPhe. Our analysis of mitoribosomes from 
multiple tissues isolated from different mammals found that of the twenty-two 
mitochondrially-encoded tRNAs, only mt-tRNAVal or mt-tRNAPhe are incorporated. 
Further, there was no evidence of tissue-specific selectivity. Remarkably, human 
mitoribosomes can exhibit adaptive plasticity when mt-tRNAVal levels are severely 
depleted by selectively integrating mt-tRNAPhe instead, to generate translationally 
competent mitoribosomes. 
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\body 
Introduction 
Mammalian mitoribosomes differ considerably from other ribosomes, primarily due to 
a reversed protein to RNA mass ratio, such that proteins predominate. Of the eighty 
known mitoribosomal proteins, thirty-six are mito-specific and lack bacterial 
orthologues, and those with orthologues often carry mito-specific extensions [1]. 
Further idiosyncrasies have been revealed by recent sub-nm resolution cryo-EM 
structures, which simultaneously resolved a long debated question concerning 
mitoribosomal rRNA content [1, 2]. Until recently, mammalian mitoribosomes were 
considered divergent by containing only one rRNA species per subunit, although the 
potential presence of the 5S species in the mitochondrial large subunit (mt-LSU) 
remained a contentious issue [3]. Recent data have shown that there is indeed a 
third RNA moiety present in mammalian mitoribosomes. It is not, however, a 5S 
species but a tRNA encoded by the mitochondrial genome (mtDNA) [1, 2, 4-6]. 
Interestingly, which tRNA was selected differed between mammalian species, with 
mt-tRNAVal predominating in human mt-LSU in contrast to mt-tRNAPhe being selected 
for incorporation into the porcine mt-LSU (Fig. 1 A, B). 
Since mammalian mtDNA encodes twenty two tRNAs [7] we sought to clarify 
whether incorporation into the mt-LSU is restricted to mt-tRNAVal and mt-tRNAPhe, or 
whether there is a more promiscuous use of mt-tRNAs in either a species- or tissue- 
specific manner. Furthermore, we investigated the consequence of reduced mt-
tRNAVal levels upon human mitoribosomes. 
 
 
Results and Discussion 
Do other mammals integrate other different mitochondrially encoded tRNAs into their 
mitoribosomes ? 
Since the overall structure of tRNAs is generically considered to be similar, the 
level of discrimination displayed in the selection of mt-tRNA was perhaps surprising. 
To identify whether there was a process that integrated mitochondrially encoded 
tRNAs, other than -tRNAVal or -tRNAPhe into the central protuberance of mammalian 
mitoribosomes, we investigated the mt-tRNA content of porcine, human, bovine and 
rat mt-LSUs. Sucrose gradient separation of cell lysates facilitated analysis of the 
distribution of RNA and mt-LSU proteins within different fractions (Fig. S1 A-C). The 
predominant mt-tRNA co-migrating with porcine and bovine mt-LSUs was mt-tRNAPhe 
(Fig. 1, C, E), whereas mt-tRNAVal was dominant in humans and rats (Fig. 1, D, F). 
The migration of other mt-tRNAs was determined, the positions of which are widely 
distributed across the encoding polycistronic transcript. None of these were 
substantially enriched amongst mt-LSU-specific fractions in any of the mammalian 
samples tested (Fig. 1, C-F). Our results indicate that only mt-tRNAVal or mt-tRNAPhe 
are integrated into mammalian mitoribosomes. 
Is there tissue-specific variation in the selection of mt-tRNA integration ? 
Having demonstrated species-specific incorporation of either mt-tRNAVal or mt-
tRNAPhe into mammalian mitoribosomes, we addressed whether within a single 
organism, there existed any tissue-specific variation. Mitoribosome sedimentation 
was performed for several mammalian tissues and the ratio of free versus mt-LSU-
bound mt-tRNA was quantified. Results indicated that mt-tRNAPhe was the principal 
tRNA in porcine mt-LSU of cardiac, hepatic, skeletal muscle, and dermal epithelium 
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(Fig. 2 A). Notably, a fraction of mt-tRNAVal was also detected in porcine mt-LSU 
across the tissues analysed. By contrast, mt-tRNAVal was consistently the dominant 
tRNA in the human, macaque and rat mt-LSU across all tissues analyzed (Fig. 2 B-
D). These data suggest that there is no tissue-specific incorporation of different mt-
tRNAs into mitoribosomes. 
Are the mt-tRNAs that are integrated as structural components post-transcriptionally 
modified ? 
Mitochondrial tRNAs undergo extensive post-transcriptional nucleotide 
modification. The structural data identified that the mt-LSU-integrated mt-tRNAs were 
matured by the addition of CCA on the 3’ terminus [6]. We therefore sought to 
determine whether any differences in nucleotide modification status existed between 
these free and mt-LSU-bound pools [8]. No changes in m1A9 modification were 
detected between the free vs integrated pools of human mt-tRNAVal (Fig. S2). This is 
consistent with the mt-LSU structures (Fig. 1), where in order to integrate into the mt-
LSU, mt-tRNAs adopt an L-shaped tertiary structure dependent on m1A9 [9]. 
What happens to mitoribosome biogenesis if levels of mt-tRNAVal are depleted ? 
Despite mt-tRNAs comprising only ~10% of the mitochondrial genome more 
than 200 disease causing mutations have been reported in these genes [10, 11]. 
Amongst these pathogenic changes is a homoplasmic m.1624C>T mutation in the 
gene encoding mt-tRNAVal (MTTV). The consequence of this particular mutation is a 
destabilization of the tRNA structure, which results in significantly reduced steady 
state levels [12, 13]. These depleted levels of mt-tRNAVal were assumed to be the 
cause of compromised mitochondrial translation in patient tissue and cell lines [13]. 
However, in light of the observation that mt-tRNAVal is a component of the 
mitoribosome, we sought to determine the effect of reduced mt-tRNAVal levels on 
mitoribosome formation. 
Individual clonal lines were derived from a cybrid population that harboured 
the homoplasmic m.1624C>T mutation. To eliminate any conflicting contribution 
resulting from the aneuploid nature of 143B cells [14], five clones were analyzed. All 
shared a consistent biochemical and molecular phenotype, including decreased 
steady state levels of mt-tRNAVal compared to the parental 143B cell line (Fig. 3 
depicts a representative clone). Experiments were designed to determine if the 
protein synthesis defect was predominantly caused by decreased amounts of 
mitoribosome due to the reduced levels of mt-tRNAVal, or if both mitoribosome 
biogenesis and translation elongation were compromised by the available mt-tRNAVal 
being distributed between integration into the mitoribosome and elongation, thus 
compromising both aspects of translation. 
The redistribution of mt-tRNAVal within sucrose gradients of the m.1624C>T 
cybrid lines was striking. The detectable majority was shifted to the free fractions, 
compared to mt-LSU association in the 143B parental controls (Fig. 3, lanes 1-3; Fig. 
S3). This was consistent with the majority of the available mt-tRNAVal being 
preferentially retained for use in elongation. Western blotting of the sucrose gradient 
fractions showed comparable levels and distribution of mitoribosomal proteins 
between the mutant and control lines. This indicated that the levels of mitoribosome 
were not directly proportional to the levels of mt-tRNAVal, despite this element 
normally being required as a structural component. 
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To examine whether the mitoribosomes had formed in the absence of any mt-
tRNA component, we probed the distribution of the remaining mt-tRNAs. All mt-
tRNAs were analyzed and retained the same profile in control and m.1624C>T cells, 
with the majority present in the fractions corresponding to the free pool, available for 
aminoacylation and elongation. The notable exception was mt-tRNAPhe, which in 
contrast to 143B parental controls, now showed a significant proportion that 
partitioned with the mt-LSU (Fig. 3, lanes 6-8; Fig. S3). These data revealed that 
when the steady state levels of mt-tRNAVal are limiting, the human mitoribosome 
displays adaptive plasticity by integrating mt-tRNAPhe into the mt-LSU. 
We have shown previously that the molecular and biochemical defects in 
m.1624C>T cell lines [12],[13] can be partially overcome by increasing levels of the 
cognate aminoacyl tRNA synthetase, VARS2, which stabilizes the mt-tRNAVal [13]. 
Therefore, to investigate whether suppression of the defect, observed with VARS2 
overexpression, was caused by the expected redistribution of mt-tRNAVal back into 
the mitoribosome, we analyzed independently-generated lines with or without 
exogenous VARS2 induction (Fig. S4). Despite the increased availability of mt-
tRNAVal, biogenesis of the mt-LSU appeared to be sensitive to the structural 
abnormality in the mutant mt-tRNAVal, as mt-tRNAPhe was preferentially retained in 
the mt-LSU (Fig. S4). This data is consistent with the partial restoration of intra-
organellar protein synthesis resulting from an increased pool of charged mt-tRNAVal 
being available for elongation. High resolution structures of mt-tRNAs, either in 
isolation or in complex with the mt-LSU, are currently lacking. It is, therefore, not 
possible to determine whether the preferential incorporation of mt-tRNAPhe into the 
mt-LSU results from a better physicochemical fit than for the mutated mt-tRNAVal. 
However, translationally active mitoribosomes are generated, irrespective of which 
mt-tRNA is integrated [13]. 
Mammalian mitoribosomes have many features that make them distinct from 
other ribosomes, even when compared to mitochondrial ribosomes from other 
organisms. Until recently, the apparent lack of a 5S rRNA was actively debated, 
particularly considering the level of conservation in its sequence, structure, and 
presence within ribosomes [15]. Although the increased proportion of protein 
components in mammalian mitoribosomes is unusual, the substitution of the 5S for a 
tRNA is currently without precedent. The 5S rRNA conservation also extends to the 
location of its gene relative to other rRNA genes in the genome [16]. Intriguingly, an 
analogous gene arrangement is found in most mammalian mitochondrial genomes, 
such that the two mt-tRNAs, which substitute for the 5S moiety in the mitoribosome, 
flank the two mt-rRNA genes (Fig. S5). This gene arrangement in mammalian 
mtDNA means that the polycistronic transcription unit encompassing both the 12S 
and 16S mt-rRNA, which is reportedly synthesized in a major excess over other units 
[17], would always include both mt-tRNAPhe and mt-tRNAVal [18]. This infers 
stoichiometric availability of these RNA species for incorporation into mt-LSU. Our 
understanding of mitoribosome biogenesis is too rudimentary to identify when the mt-
tRNA is incorporated but based on the positioning of the cleaved termini of the 16S 
and the mt-tRNAVal, it seems unlikely that a polycistronic element is incorporated into 
the mt-LSU and subsequently cleaved. The context for CCA addition once integrated 
in the mt-LSU would be very different to all the other mt-tRNAs, perhaps suggesting 
that this occurs prior to incorporation and therefore not when the mt-tRNA is part of a 
polycistronic unit. Since we know that certain mammals and, under certain 
circumstances, human mitoribosomes incorporate mt-tRNAPhe in preference to mt-
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tRNAVal, it seems unlikely that a ~2.5knt RNA would be associated with the 
assembling mt-LSU prior to a cleavage event that would release the required mt-
tRNAPhe. 
The mammalian mitoribosome has substituted an mtDNA-encoded -tRNA for 
the 5S rRNA as a third structural RNA component. It has been well documented that 
mitochondrial RNase P is a protein only complex that does not require RNA import 
into the mitochondrial matrix [19]. Together, these observations support the absence 
of a functional requirement for RNA import into mammalian mitochondria. 
In summary, the structural evidence for mt-tRNA incorporation, and the 
conserved positions of mammalian mtDNA genes suggests an evolutionary 
significance of gene arrangement that would promote coordinated transcription of the 
RNA species destined to be structural components of the mt-LSU. The inclusion of 
two mt-tRNAs within this highly transcribed unit provides a degree of plasticity to the 
process of mitoribosome biogenesis, as seen by the differing usage between 
organisms and the adaptive response observed under conditions of limiting mt-
tRNAVal. What controls the selection of a specific mt-tRNA, despite the relative 
similarities in structure, or whether other mt-tRNAs can be used when levels of both 
these species are limiting is yet to be determined. 
 
 
Materials and Methods 
Cell culture 
All cell lines used in this study were standard, commercially available cell lines 
except for the m.1624C>T transmitochondrial cybrid 143B lines, which used 
cytoplasts from patient cell lines that were derived from donated tissue samples. 
Access to samples that were excess to diagnostic requirements and were approved 
for research, was covered by the licence ‘Role of mitochondrial abnormalities in 
disease’ (REC ref 2002/205) issued by Newcastle and North Tyneside Local 
Research Ethics Committee. Human 143B.206 Rho+ cells and cybrid derivatives 
were cultured (37˚C, humidified 5% CO2) in DMEM (Sigma) supplemented with 10% 
(v/v) foetal calf serum, 1x non-essential amino acids and 2mM L-glutamine. Where 
appropriate BlasticidinS (10 µg/ml) and HygromycinB (100 µg/ml) were added to 
select for successful integration and retention of the VARS2 gene. VARS2 induction 
was achieved by addition of 1µg/ml tetracycline for 14 days. 
 
Mitochondrial transcript analysis 
Total RNA from the relevant tissues was extracted using TRIzol (ThermoFisher 
Scientific) and treated with Turbo DNase following manufacturer’s protocols. 
Northern blot analysis was essentially as previously performed [20], total RNA was 
resolved on 6 or 15% UREA-PAGE (mt-tRNAs), subjected to wet transfer in 2x SSC 
to a nylon membrane (MAGNEPROBE, 0.45µ, GE Healthcare or Genescreenplus, 
NEN DuPont). Following UV-Crosslinking (0.120 J), membranes were hybridized with 
radioactive probes, corresponding to mt-tRNAs, overnight at 65°C in 7% SDS and 
0.25 M sodium phosphate buffer (pH 7.6), washed with 1x SSC (150 mM sodium 
chloride and 15 mM sodium citrate, pH 7.0) three times for 20 min and then three 
times with 1x SSC containing 0.1% SDS (20 min; 65°C). The membranes were 
exposed to a storage phosphor screen (GE Healthcare), visualized in using a 
Typhoon phosphorimaging system and quantified using ImageQuant software 
(Molecular Dynamics, GE Healthcare) or ImageJ (http://imagej.nih.gov/ij). 
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To analyse modifications RNA was extracted using Trizol reagent (ThermoFisher 
Scientific) following the manufacturers instructions from sucrose gradient fractions as 
indicated. The reverse transcription primer extension (RT-PEx) was as in [21], the 
specific 5′ 32P-labeled primer (0.1 pmol) was incubated with 0.5 – 1 μg of the RNA 
isolated from sucrose gradient fractions and subjected to reverse transcription 
reactions as described by [22]. The reaction mixture was separated by 12.5% 
(vol/vol) PAGE containing 7 M urea and dried gels were exposed to a storage 
phosphor screen and scanned as above. The following primers were used in RT-
PEx: 
mt-tRNAVal: 5’-GTAAGTTGGGTGCTTTGTGTT 
mt-tRNAPhe: 5’-TCAGTGTATTGCTTTGAGGAGGT 
 
Analysis of mitochondrial ribosomal protein profile on isokinetic sucrose density 
gradients 
Mitochondria were isolated from indicated tissues as previously described [23]. 
Cultured cells or mitochondria isolated from the tissues were lysed in buffer 
containing 50 mM Tris-HCl (pH 7.2), 1% Triton X-100, 10 mM Mg(OAc)2, 100 mM 
NaCl EDTA-free complete protease inhibitor (Roche), and 0.08 U/ml RNAsin 
(Promega). The lysates (0.7 mg and 0.1 mg of cell and mitochondrial lysates, 
respectively) were loaded on a linear sucrose gradient (2 ml 10–30% (v/v)) in 50 mM 
Tris–HCl (pH 7.2), 10 mM Mg(OAc)2, 80 mM NH4Cl, 0.1 M KCl, 1 mM PMSF and 
centrifuged for 2 h 15 min at 100 000 g max at 4°C (39,000 rpm, Beckman Coulter 
TLS-55 rotor). Fractions (15 x 100 μl) were collected and 10 μl aliquots were 
analyzed directly by western blotting with the following antibodies; bL12m (PTG labs 
14795-1-AP), uL3m (Abcam ab39268), mS29 (Abcam ab11928), mS40 (PTG labs 
16139-1-AP), uL11m (CST D68F2). 
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Figure legends 
 
Fig. 1 Species and tissue specific variation in mt-tRNA incorporation into the mt-LSU 
was analysed. Depicted are the overall structures of porcine (A) and human (B) mt-
LSUs, detailing the region of the central protuberance containing mt-tRNAPhe (porcine) 
or mt-tRNAVal (human). The mitoribosomal proteins in direct contact with the mt-LSU-
incorporated mt-tRNA are indicated in dark blue. Human (PDB: 3J9M); Porcine (PDB: 
5AJ4). (C-F) In order to analyse and quantify species-specific mt-tRNA distributions, 
high resolution northern blots of sucrose gradients were performed. Analysis of porcine 
dermal fibroblasts (C), human osteosarcoma 143B cells (D), bovine cardiac tissue (E) 
and rat hepatic tissue (F) depicts the relative abundance of each mt-tRNA across 
fractions (ImageQuant software); represented as a percentage of the total signal. 
 
Fig. 2 Determination of tissue specific variation in mt-tRNA incorporation into the 
mammalian mt-LSU. Selected tissues and cultured cells isolated from (A) pig (heart, 
liver, skeletal muscle and dermal fibroblasts), (B) human (osteoblasts and embryonic 
kidney cells), (C) macaque (heart and liver) and (D) rat (heart, liver, skeletal muscle, 
brain and kidney) were analyzed to determine any tissue specific variation in mt-
tRNA incorporation into the mt-LSU. Upon lysis, the samples were sedimented 
through sucrose gradients, followed by RNA extraction. RNA samples from fractions 
1 and 2 (free pool) and fractions 10 and 11 (mt-LSU-associated) were subjected to 
northern blotting. Abundance of mt-tRNAPhe (green) and mt-tRNAVal (orange) in free 
(pale green/orange), and mt-LSU-associated fractions (dark green/orange) is 
represented as a percentage of their combined signal. 
 
Fig. 3 The integration of mt-tRNAVal or mt-tRNAPhe into mitoribosomes of control 
cells or those harbouring the MTTV mutation m.1624C>T was analysed by 
sucrose gradient. Cell lysates from control 143B parental (A) and m.1624C>T (B) 
lines were separated through 10-30% sucrose gradients and fractions collected 
(1=top; 11=bottom). Both RNA (above) and proteins (below) were extracted and 
analysed to determine the relative positions of mitoribosomal proteins (MRP) and 
mt-tRNAVal, mt-tRNAPhe with mt-tRNAAsn as a control. The representative images 
are, in each case, the same membranes sequentially probed for different mt-
tRNAs or MRPs respectively. 



